Kevin Herde's Insider Trades & SAST Disclosures
Kevin Herde's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 876 Class A Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin Herde.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 15 May 2025 | 876 | 674,636 | - | 1.7 | 1,463 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 394,478 | 673,760 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.64 per share. | 17 Mar 2025 | 8,648 | 279,282 | - | 2.6 | 22,831 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 18 Feb 2025 | 2,326 | 287,930 | - | 4.1 | 9,537 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 46,344 | 290,256 | - | 4.6 | 211,329 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 31 Oct 2024 | 1,906 | 336,600 | - | 5.7 | 10,864 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 30 Apr 2024 | 1,780 | 334,694 | - | 5.7 | 10,146 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 15 Mar 2024 | 8,624 | 332,914 | - | 7.7 | 66,405 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 15 Feb 2024 | 2,664 | 341,538 | - | 5.5 | 14,599 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Herde Kevin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 250,277 | 344,202 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 11.72 per share. | 28 Apr 2023 | 874 | 92,064 | - | 11.7 | 10,243 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 143,000 | 143,000 | - | - | Employee Stock Options (Right to Buy) | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 72,507 | 91,190 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 15 Feb 2023 | 2,611 | 18,683 | - | 15.2 | 39,766 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 14.11 per share. | 31 Oct 2022 | 478 | 21,294 | - | 14.1 | 6,745 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 29 Apr 2022 | 427 | 20,816 | - | 23.0 | 9,800 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 36,200 | 36,200 | - | - | Employee Stock Option (Right to Buy) | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 19,500 | 20,389 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 497 | 497 | - | 22.9 | 11,406 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 392 | 889 | - | 22.9 | 8,996 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kevin Herde | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 60,000 | 60,000 | - | - | Employee Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges